Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nurses for Laughter

B Bergstrom

    Hospital Forum
    |August 8, 1984
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Use of a Digital Computer For Studying Velocity Judgements of Radar Targets.

    Ergonomics·2017
    Same author

    An approach for manganese biomonitoring using a manganese carrier switch in serum from transferrin to citrate at slightly elevated manganese concentration.

    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)·2015
    Same author

    Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2008
    Same author

    Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases.

    Annals of oncology : official journal of the European Society for Medical Oncology·2007
    Same author

    Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: phase III trial results.

    European journal of cancer care·2006
    Same author

    Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer.

    European journal of cancer (Oxford, England : 1990)·2004